Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer

Abstract

Androgen deprivation therapy in men with prostate cancer is associated with the diagnosis of nonalcoholic fatty liver disease. The usual limitations of an observational study design apply, including possible inaccuracy in defining outcomes in a population based registry.